臨床試驗

Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)

NCT：NCT06898515 · RECRUITING

NCT IDNCT06898515

狀態RECRUITING

開始日期2025-07-14

SponsorReprieve Cardiovascular, Inc (INDUSTRY)

First posted2025-03-27

Last updated2026-10-08

簡要摘要

The objective of this study is to prospectively compare decongestive therapy administered by the Reprieve System to Optimal Diuretic Therapy (ODT) in the treatment of patients diagnosed with acute decompensated heart failure (ADHF). The main objective is to determine if the Reprieve System can more efficiently decongest ADHF patients in comparison to Control Therapy.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。